AI ScreeningAI ChatPricing
  1. US-listed companies
  2. COSCIENS Biopharma Inc.
  3. Financials
  4. Operating margin (%)

COSCIENS Biopharma Inc.【CSCIF】

Market cap
$87.12M
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2024-190.7-52.37%
Dec 31, 2023-400.4-4.33%
Dec 31, 2022-418.5+153.87%
Dec 31, 2021-164.8+5.51%
Dec 31, 2020-156.2-91.88%
Dec 31, 2019-1,925.2-5358.18%
Dec 31, 201836.6-101.46%
Dec 31, 2017-2,499.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)